NOS2 and gastric cancer: Distinct molecular patterns between cardiac and non-cardiac GC with upregulated expression of pro-inflammatory and pro-oxidative NOS2 and immunosuppressive IL10 might contribute, in turn, to worse prognosis associated with cardiac GC subtype.